4.7 Article

Early Forms of α-Synuclein Pathology Are Associated with Neuronal Complex I Deficiency in the Substantia Nigra of Individuals with Parkinson's Disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Neurosciences

Reverse engineering Lewy bodies: how far have we come and how far can we go?

Mohamed Bilal Fares et al.

Summary: Lewy bodies (LBs) are important pathological features of Parkinson disease and other neurodegenerative diseases, with increasing evidence suggesting that the aggregation of alpha-synuclein plays a central role in LB formation. However, little is known about the mechanisms underlying LB formation, their biochemical and ultrastructural properties, evolution and spreading with disease progression, and their role in neurodegeneration.

NATURE REVIEWS NEUROSCIENCE (2021)

Article Multidisciplinary Sciences

Disruption of mitochondrial complex I induces progressive parkinsonism

Patricia Gonzalez-Rodriguez et al.

Summary: Loss of functional mitochondrial complex I in dopaminergic neurons can lead to a shift in metabolism in mice, causing Parkinson's disease-like symptoms. This study challenges the traditional paradigm of Parkinson's disease by showing that dysfunction of mitochondrial complex I alone is sufficient to cause progressive parkinsonism.

NATURE (2021)

Article Neurosciences

Is there a special relationship between complex I activity and nigral neuronal loss in Parkinson's disease? A critical reappraisal

Nitya Subrahmanian et al.

Summary: Parkinson's disease is a progressive neurodegenerative disorder characterized by motor and non-motor symptoms, with possible involvement of mitochondrial complex I deficiency. Studies have analyzed the prevalence of complex I defects in PD and their association with nigral cell loss.

BRAIN RESEARCH (2021)

Review Medicine, General & Internal

Parkinson's disease

Bastiaan R. Bloem et al.

Summary: Parkinson's disease is a neurodegenerative condition with diverse causes and clinical presentations. Diagnosis is clinically based, and treatment goals vary from person to person, emphasizing the need for personalized management. Currently, there is no therapy to slow down or arrest the progression of Parkinson's disease.

LANCET (2021)

Article Medicine, Research & Experimental

Oxidative stress in vagal neurons promotes parkinsonian pathology and intercellular α-synuclein transfer

Ruth E. Musgrove et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

Article Biochemistry & Molecular Biology

Alpha-synuclein mitochondrial interaction leads to irreversible translocation and complex I impairment

Jimena H. Martinez et al.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2018)

Article Clinical Neurology

Increased Oxidative Stress Exacerbates α-Synuclein Aggregation In Vivo

Owen Scudamore et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2018)

Article Multidisciplinary Sciences

α-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson's disease

Marthe H. R. Ludtmann et al.

NATURE COMMUNICATIONS (2018)

Review Neurosciences

The Close Encounter Between Alpha-Synuclein and Mitochondria

Mattia Vicario et al.

FRONTIERS IN NEUROSCIENCE (2018)

Article Clinical Neurology

Rare genetic variation in mitochondrial pathways influences the risk for Parkinson's disease

Johannes J. Gaare et al.

MOVEMENT DISORDERS (2018)

Review Biochemistry & Molecular Biology

α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies

Yvette C. Wong et al.

NATURE MEDICINE (2017)

Review Neurosciences

Selective neuronal vulnerability in Parkinson disease

D. James Surmeier et al.

NATURE REVIEWS NEUROSCIENCE (2017)

Article Clinical Neurology

Investigating complex I deficiency in Purkinje cells and synapses in patients with mitochondrial disease

A. Chrysostomou et al.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2016)

Article Clinical Neurology

Mitochondrial DNA Depletion in Respiratory Chain-Deficient Parkinson Disease Neurons

Anne Gruenewald et al.

ANNALS OF NEUROLOGY (2016)

Article Multidisciplinary Sciences

Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease

Christian Dolle et al.

NATURE COMMUNICATIONS (2016)

Article Clinical Neurology

Molecular Pathogenesis of Polymerase Gamma-Related Neurodegeneration

Charalampos Tzoulis et al.

ANNALS OF NEUROLOGY (2014)

Review Physiology

Lysosomal Acidification Mechanisms

Joseph A. Mindell

ANNUAL REVIEW OF PHYSIOLOGY, VOL 74 (2012)

Article Clinical Neurology

Relationship Between Mitochondria and α-Synuclein A Study of Single Substantia Nigra Neurons

Amy K. Reeve et al.

ARCHIVES OF NEUROLOGY (2012)

Article Medicine, Research & Experimental

Parkinson's Disease and Parkinsonism: Neuropathology

Dennis W. Dickson

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)

Article Clinical Neurology

Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study

G. Alves et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)

Article Biochemistry & Molecular Biology

ATP binding and ATP hydrolysis play distinct roles in the function of 26S proteasome

Chang-Wei Liu et al.

MOLECULAR CELL (2006)

Article Neurosciences

Mice lacking alpha-synuclein are resistant to mitochondrial toxins

P Klivenyi et al.

NEUROBIOLOGY OF DISEASE (2006)

Review Geriatrics & Gerontology

Staging of brain pathology related to sporadic Parkinson's disease

H Braak et al.

NEUROBIOLOGY OF AGING (2003)

Article Neurosciences

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

R Betarbet et al.

NATURE NEUROSCIENCE (2000)